Arginase inhibition enhances angiogenesis in endothelial cells exposed to hypoxia

Microvascular Research

Volumn 98, Issue , 2015, Pages 1-8

  Wang, Lin ^a,b   Bhatta, Anil ^b   Toque, Haroldo A ^b   Rojas, Modesto ^b   Yao, Lin ^b   Xu, Zhimin ^b   Patel, Chintan ^b   Caldwell, Ruth B ^b   Caldwell, R William ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Angiogenesis; Arginase; Endothelial cell; Endothelial nitric oxide synthase (eNOS); Reactive oxygen species (ROS)

Indexed keywords

ARGINASE; ARGINASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SERINE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; AORTA; ARTICLE; BIOSYNTHESIS; CELL HYPOXIA; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; ANIMAL; ANTAGONISTS AND INHIBITORS; BOVINE; CYTOLOGY; ENZYMOLOGY; HYPOXIA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

BOVINAE;

ANIMALS; AORTA; ARGINASE; CATTLE; CELL HYPOXIA; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HYPOXIA; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE OXYGEN SPECIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84924856530     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2014.11.002     Document Type: Article

References (45)

1. Abe H., Ishikawa W., Kushima T., Nishimura T., Mori C., Onuki A., Suzuki T., Ishii Y., Kansaku N., Miyazaki Y., Tanaka K., Morita H., Takizawa T. Nitric oxide induces vascular endothelial growth factor expression in the rat placenta in vivo and in vitro. Biosci. Biotechnol. Biochem. 2013, 77:971-976.
2. Ahluwalia A., Tarnawski A.S. Critical role of hypoxia sensor-HIF-1alpha in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr. Med. Chem. 2012, 19:90-97.
3. Berchner-Pfannschmidt U., Tug S., Kirsch M., Fandrey J. Oxygen-sensing under the influence of nitric oxide. Cell. Signal. 2010, 22:349-356.
4. Chandra S., Romero M.J., Shatanawi A., Alkilany A.M., Caldwell R.B., Caldwell R.W. Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br. J. Pharmacol. 2012, 165:506-519.
5. Dulak J., Jozkowicz A., Dembinska-Kiec A., Guevara I., Zdzienicka A., Zmudzinska-Grochot D., Florek I., Wojtowicz A., Szuba A., Cooke J.P. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2000, 20:659-666.
6. Fong G.H. Regulation of angiogenesis by oxygen sensing mechanisms. J. Mol. Med. (Berl) 2009, 87:549-560.
7. Forstermann U., Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006, 113:1708-1714.
8. Fraisl P. Crosstalk between oxygen- and nitric oxide-dependent signaling pathways in angiogenesis. Exp. Cell Res. 2013, 319:1331-1339.
9. Gao X., Xu X., Belmadani S., Park Y., Tang Z., Feldman A.M., Chilian W.M., Zhang C. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1269-1275.
10. Gao L., Chen Q., Zhou X., Fan L. The role of hypoxia-inducible factor 1 in atherosclerosis. J. Clin. Pathol. 2012, 65:872-876.
11. Gonon A.T., Jung C., Katz A., Westerblad H., Shemyakin A., Sjoquist P.O., Lundberg J.O., Pernow J. Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production. PLoS One 2012, 7:e42038.
12. Haddad P., Dussault S., Groleau J., Turgeon J., Michaud S.E., Menard C., Perez G., Maingrette F., Rivard A. Nox2-containing NADPH oxidase deficiency confers protection from hindlimb ischemia in conditions of increased oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1522-1528.
13. Hoffmann A., Gloe T., Pohl U. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J. Cell. Physiol. 2001, 188:33-44.
14. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., Rhodes P., Westmore K., Emson P.C., Moncada S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:4392-4396.
15. Jones M.K., Tsugawa K., Tarnawski A.S., Baatar D. Dual actions of nitric oxide on angiogenesis: possible roles of PKC, ERK, and AP-1. Biochem. Biophys. Res. Commun. 2004, 318:520-528.
16. Jung C., Gonon A.T., Sjoquist P.O., Lundberg J.O., Pernow J. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovasc. Res. 2010, 85:147-154.
17. Khong S.M., Andrews K.L., Huynh N.N., Venardos K., Aprico A., Michell D.L., Zarei M., Moe K.T., Dusting G.J., Kaye D.M., Chin-Dusting J.P. Arginase II inhibition prevents nitrate tolerance. Br. J. Pharmacol. 2012, 166:2015-2023.
18. Kim J.H., Bugaj L.J., Oh Y.J., Bivalacqua T.J., Ryoo S., Soucy K.G., Santhanam L., Webb A., Camara A., Sikka G., Nyhan D., Shoukas A.A., Ilies M., Christianson D.W., Champion H.C., Berkowitz D.E. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol (1985) 2009, 107(4):1249-1257. [Electronic publication ahead of print 2009 Aug 6]. 10.1152/japplphysiol.91393.2008.
19. Kimura H., Esumi H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim. Pol. 2003, 50:49-59.
20. Kimura H., Weisz A., Kurashima Y., Hashimoto K., Ogura T., D'Acquisto F., Addeo R., Makuuchi M., Esumi H. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 2000, 95:189-197.
21. Kimura H., Weisz A., Ogura T., Hitomi Y., Kurashima Y., Hashimoto K., D'Acquisto F., Makuuchi M., Esumi H. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J. Biol. Chem. 2001, 276:2292-2298.
22. Krause B.J., Prieto C.P., Munoz-Urrutia E., San Martin S., Sobrevia L., Casanello P. Role of arginase-2 and eNOS in the differential vascular reactivity and hypoxia-induced endothelial response in umbilical arteries and veins. Placenta 2012, 33:360-366.
23. Krotova K., Patel J.M., Block E.R., Zharikov S. Hypoxic upregulation of arginase II in human lung endothelial cells. Am. J. Physiol. Cell Physiol. 2010, 299:C1541-C1548.
24. Kuwahara F., Kai H., Tokuda K., Shibata R., Kusaba K., Tahara N., Niiyama H., Nagata T., Imaizumi T. Hypoxia-inducible factor-1/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension 2002, 39:46-50.
25. Madigan M., Zuckerbraun B. Therapeutic potential of the nitrite-generated NO pathway in vascular dysfunction. Front. Immunol. 2013, 4:174.
26. Ming X.F., Barandier C., Viswambharan H., Kwak B.R., Mach F., Mazzolai L., Hayoz D., Ruffieux J., Rusconi S., Montani J.P., Yang Z. Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation 2004, 110:3708-3714.
27. Morris S.M. Regulation of enzymes of the urea cycle and arginine metabolism. Annu. Rev. Nutr. 2002, 22:87-105.
28. Morris S.M. Recent advances in arginine metabolism: roles and regulation of the arginases. Br. J. Pharmacol. 2009, 157:922-930.
29. Morris C.R., Gladwin M.T., Kato G.J. Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Curr. Mol. Med. 2008, 8:620-632.
30. Prieto C.P., Krause B.J., Quezada C., San Martin R., Sobrevia L., Casanello P. Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistribution in human umbilical vein endothelium. Placenta 2011, 32:932-940.
31. Reid K.M., Tsung A., Kaizu T., Jeyabalan G., Ikeda A., Shao L., Wu G., Murase N., Geller D.A. Liver I/R injury is improved by the arginase inhibitor, N(omega)-hydroxy-nor-l-arginine (nor-NOHA). Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G512-G517.
32. Romero M.J., Platt D.H., Tawfik H.E., Labazi M., El-Remessy A.B., Bartoli M., Caldwell R.B., Caldwell R.W. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ. Res. 2008, 102:95-102.
33. Ryoo S., Lemmon C.A., Soucy K.G., Gupta G., White A.R., Nyhan D., Shoukas A., Romer L.H., Berkowitz D.E. Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ. Res. 2006, 99:951-960.
34. Sankaralingam S., Xu H., Davidge S.T. Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia. Cardiovasc. Res. 2010, 85:194-203.
35. Sasaki A., Doi S., Mizutani S., Azuma H. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L1480-L1487.
36. Shatanawi A., Romero M.J., Iddings J.A., Chandra S., Umapathy N.S., Verin A.D., Caldwell R.B., Caldwell R.W. Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway. Am. J. Physiol. Cell Physiol. 2011, 300:C1181-C1192.
37. Singh M., Padhy G., Vats P., Bhargava K., Sethy N.K. Hypobaric hypoxia induced arginase expression limits nitric oxide availability and signaling in rodent heart. Biochim. Biophys. Acta 2014, 1840:1817-1824.
38. Steppan J., Nyhan D., Berkowitz D.E. Development of novel arginase inhibitors for therapy of endothelial dysfunction. Front. Immunol. 2013, 4:278.
39. Takemoto M., Sun J., Hiroki J., Shimokawa H., Liao J.K. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 2002, 106:57-62.
40. Takenaga K. Angiogenic signaling aberrantly induced by tumor hypoxia. Front. Biosci. (Landmark Ed.) 2011, 16:31-48.
41. Thengchaisri N., Hein T.W., Wang W., Xu X., Li Z., Fossum T.W., Kuo L. Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2035-2042.
42. Webster K.A. Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Futur. Cardiol. 2012, 8:863-884.
43. Xu W., Kaneko F.T., Zheng S., Comhair S.A., Janocha A.J., Goggans T., Thunnissen F.B., Farver C., Hazen S.L., Jennings C., Dweik R.A., Arroliga A.C., Erzurum S.C. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J. 2004, 18:1746-1748.
44. Yang Z., Ming X.F. Endothelial arginase: a new target in atherosclerosis. Curr. Hypertens. Rep. 2006, 8:54-59.
45. Zhang W., Baban B., Rojas M., Tofigh S., Virmani S.K., Patel C., Behzadian M.A., Romero M.J., Caldwell R.W., Caldwell R.B. Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. Am. J. Pathol. 2009, 175:891-902.